Skip to Main Content
Our Commitment to Diversity

REPRESENTATIVE EXPERIENCE

Oded Green

MERGERS AND ACQUISITIONS

Represented Singapore Technologies Kinetics, a public company, in its acquisition of Aethon, a developer of autonomous mobile robots for manufacturing environments, hospitals and other commercial settings.
Represented CardiacAssist dba Tandem Life, a medical device company, in its sale to LivaNova, a British public pharmaceutical company ($250 million).
Represented Jvion, a software company in the AI healthcare space, in connection with a growth equity investment of JMI.
Represented W.G. Saterlee and Sons, a wholesale fule distributor, to Cleopatra Resources.
Represented Knopp Neurosciences Inc. in its $355 million strategic license with Biogen Idec, Inc. for Knoppā€™s ALS Drug.
Represented a developer of a drug for the treatment of colon cancer (located in China and the U.S.) in its negotiations with a leading pharmaceutical company for an investment and a related option to acquire the Company.
Represented a university in the sale of its portfolio of software, education, internet and technology companies.
Represented Sunbury Textile Mills, a producer of fabrics, in its sale to Glen Raven Inc.
Represented Atlantic Plywood Corporation, a wholesale supplier of hardwood plywood and panel products, in its sale to Parksite Inc.

Represented a credit card processing company in a series of acquisitions.

Represented Universal Stainless, a publicly-held company, in its acquisition of a metal forging facility and a related bank financing.

Represented a chain of supply consulting company in connection with the sale of its assets.

Represented a construction software company in connection with the sale of its business.

Represented a developer of lane departure warning systems in connection with the sale of its business to a publicly-held company.

VENTURE CAPITAL TRANSACTIONS; STRATEGIC INVESTMENTS

Represented a drug discovery company in connection with various rounds of equity raise (over $85 million) and convertible debt raise (over $30 million).

Represented a public benefit corporation that transforms plastic waste from the developing world into socially and environmentally responsible fabric, in connection with several rounds of offering to a venture capital fund, foundations and non-for-profit organizations.

Represented an insurance company in its $150 million investment in a fund.

Represented a U.S. foundation in its investment in a Singapore company.

Represented a company in the healthcare AI space, in its Series A round of financing.

Represented a developer of a personal air quality monitor in a strategic investment by a U.S. company, and a related Joint Development Agreement.

Structured the formation and fundraise of a fund for the purchase and reconstruction of distressed real estate properties.

Represented a high-tech baby gear company in connection with two venture capital investments in the aggregate amount of $60 million.

Represented a technology company in the railroad industry in connection with several rounds of private offerings, and a related joint venture arrangement with a public railroad company.

Represented an academic institution in connection with its structuring of an early stage accelerator for life sciences companies.

COMMERCIAL CONTRACTS

Represented an organ regeneration company in its licensing of technology, clinical trials, research and development, and other commercial needs.

Advised a global company in connection with its contract lifecycle management (distribution, sales, and supply).

Represented a high-tech baby gear company in the license of its technology to a global toy manufacturer ($215 million).

Represented a technology company in the railroad industry in connection with several rounds of private offerings, and a related joint venture arrangement with a public railroad company.

Represented a developer of an OTC drug for the treatment of opioid overdose in its development, clinical testing and production arrangements.

Represented a company that develops a set of health tools using behavioral decision science/machine learning to engage patients in their clinical care in the company's joint venture with a leading hospital.

Represented a diagnostic company in a Joint Development Agreement related to the development, production and supply of molecularly imprinted nanoparticles (nanoMIPs).

Drafted a full set of commercial contracts for a provider of a SaaS-based online fraud detection platform and a provider of a SaaS-based automated translation platform.

Represented a company that develops RFID storage and tracking solutions for healthcare providers in connection with its commercialization and marketing agreement with a multinational pharmaceutical and life sciences company.

Represented a video games company in its negotiations of a joint development and commercialization agreement with an education toy company.

ISRAELI RELATED MATTERS

Represented TDJ Pitango Ventures, a Polish-Israeli venture capital, in its investment in Cosmose, a marketing software company.

Represented TDJ Pitango Ventures, a Polish-Israeli venture capital fund, in its investment in Neptune.ml, a developer of machine learning models.

Represented a venture capital firm focusing on ophthalmology in connection with its investment in an Israeli company (Series B round).

Represented a Chinese venture capital fund in its investment in an Israeli company that develops and supplies ceramic and metal additive manufacturing technologies and solutions.

Represented a Chinese venture capital fund in its investment in an Israeli company that develops a quick charging battery for the use with phones, electric cars and other non-wired devices.

Represented a U.S. company in connection with its on-going relationship with the Israeli Railroad Company.

Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel